Skip to main content
    W

    Waystar Holding Corp. Common Stock (WAY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $28.24
    +1.37 (+5.10%)

    Market Cap: $5.15B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    89%(8/9)
    Avg Surprise
    +50.50%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.41
    Range$0.36 - $0.43
    20 analysts
    EPS Revisions
    1
    0
    7d
    7
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$0.41-0.0%
    60d ago$0.41-0.1%
    30d ago$0.41-0.1%
    7d ago$0.41-0.1%
    Current$0.41
    Revenue Consensus
    $323M
    Range$320M - $328M
    20 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.48
    Range$0.39 - $0.57
    22 analysts
    Revenue Consensus
    $335M
    Range$326M - $343M
    22 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.48---
    Sep 26EST
    		-$0.41---
    Jun 26
    Reported Jul 29
    		$0.37$0.35+5.71%Beat+2.8%
    Mar 26
    Reported Apr 29
    		$0.42$0.39+7.69%Beat+31.2%
    Dec 25
    Reported Feb 17
    		$0.36$0.40-8.98%Miss+24.1%
    Sep 25
    Reported Oct 29
    		$0.37$0.35+5.71%Beat+164.3%
    Jun 25
    Reported Jul 30
    		$0.36$0.34+5.88%Beat+800.0%
    Mar 25
    Reported Apr 30
    		$0.32$0.32+0.00%Beat+900.0%
    Dec 24
    Reported Feb 18
    		$0.29$0.14+107.29%Beat-
    Sep 24
    Reported Nov 6
    		$0.14$0.11+31.21%Beat-
    Jun 24
    Reported Aug 7
    		$0.04$-0.02+300.00%Beat-
    Mar 24
    Reported Jun 12
    		$-0.04$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio18.58EV/EBITDA15.80x
    Price/FCF22.00xFCF Yield4.54%
    Profitability
    Profit Margin11.20%Operating Margin24.40%
    ROE3.77%ROIC3.49%
    Financial Health
    Debt/Equity0.37xInterest Coverage3.42x
    Current Ratio1.85xQuick Ratio1.85x
    Trading Statistics
    Beta0.18Avg Volume2.10M
    52-Week High$40.3552-Week Low$17.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$26.47
    SMA 20$25.86
    SMA 50$25.31
    SMA 200$24.10
    EMA 10$26.61
    EMA 20$26.11
    EMA 50$25.15
    EMA 200$25.60

    MACD

    Line: 0.59Signal: 0.41Hist: 0.18

    ADX

    ADX: 22.3+DI: 30.5-DI: 11.3

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$24.65

    Bollinger Bands

    Upper Band$27.68
    Lower Band$24.05
    %B Position1405%(Upper)
    Band Width1.15

    RSI (14-Day)

    Neutral
    66.4

    Momentum Oscillators

    Stoch %K76.8
    Stoch %D75.6
    Williams %R-3.9
    ROC (10d)11.4%
    Momentum2.89
    CCI (20d)209.2
    MFI (14d)59.2

    Volatility Measures

    ATR (14d)$1.14(4.0%)
    StdDev (20d)0.91
    Hist Vol43.3%(High)

    Volume Flow

    VWAP$27.86
    OBV19.3M
    AD Line-48.1M
    CMF (20d)0.058

    Volume Metrics

    Avg Vol (20d)2.0M
    Vol Ratio1.7x(High)
    VWMA (20d)$26.06

    Pivot Points

    R3$28.40
    R2$27.74
    R1$27.30
    Pivot Point$26.64
    S1$26.20
    S2$25.54
    S3$25.10

    Advanced Oscillators

    TSI15.61
    Ultimate Osc55.3
    KST46.31

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$319.67M$313.87M$303.54M$268.65M$270.65M$256.44M$244.10M$240.11M$234.54M$224.79M$206.69M$197.26M
    Cost of Revenue$0$97.03M$348.16M$0$0$0$235.19M$80.55M$0$0$67.19M$0
    Gross Profit$319.67M$216.84M$-44,624,000$268.65M$270.65M$256.44M$8.92M$159.57M$234.54M$224.79M$139.51M$197.26M
    Operating Expenses$243.63M$136.37M$-103,642,000$208.42M$205.81M$191.23M$-44,226,000$132.42M$226.30M$189.60M$101.82M$165.05M
    R&D$17.72M$18.37M$18.52M$12.40M$12.62M$11.08M$11.47M$11.08M$15.90M$10.32M$9.78M$8.97M
    SG&A$36.38M$30.72M$43.71M$32.42M$29.19M$23.30M$22.96M$22.70M$39.95M$26.14M$16.40M$17.36M
    Operating Income$76.04M$80.47M$59.02M$60.23M$64.85M$65.21M$53.14M$27.15M$8.24M$35.19M$37.69M$32.22M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$19.65M$20.65M$22.87M$17.52M$18.25M$18.90M$20.09M$18.46M$50.54M$57.18M$52.86M$52.41M
    Income Before Tax$56.40M$59.82M$36.15M$42.72M$46.59M$46.31M$33.06M$8.69M$-42,296,000$-21,993,000$-15,172,000$-20,195,000
    Income Tax Expense$15.53M$16.54M$16.16M$12.07M$14.41M$17.04M$13.98M$3.27M$-14,611,000$-6,061,000$-757,000$-4,709,000
    Net Income$40.87M$43.28M$19.99M$30.65M$32.18M$29.27M$19.08M$5.41M$-27,685,000$-15,932,000$-14,415,000$-15,486,000
    EBITDA$118.18M$122.58M$100.14M$94.21M$98.95M$99.26M$91.78M$87.99M$53.49M$81.05M$82.41M$78.58M
    EBIT$76.04M$80.47M$59.02M$60.23M$64.85M$65.21M$53.14M$27.15M$8.24M$35.19M$37.69M$32.22M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about WAY

    News

    Waystar schedules November 2 results. Waystar stock stands at EUR 24.10

    Waystar has scheduled its third-quarter 2026 results release for November 2, 2026, with a conference call set for 4:30 p.m. Eastern Time. The company's stock was trading at EUR 24.10 at Lang & Schwarz on October 15...

    ad-hoc-news.de•10/15/26•Neutral

    A 4:30 p.m. call will cover Waystar's third-quarter results on Nov. 2.

    Waystar (WAY) is scheduled to report its third-quarter 2026 financial results after market close on November 2, 2026, for the quarter ending September 30...

    Stock Titan•10/14/26•Neutral

    Waystar to Report Third Quarter 2026 Financial Results on November 2, 2026

    Waystar Holding Corp. announced it will report its third-quarter 2026 financial results after market close on Monday, November 2, 2026. A conference call will follow at 4:30 p.m. Eastern Time...

    The Herald Journal•10/14/26•Neutral

    Form 144 Waystar Holding Corp. For: 11 October By Investing.com

    This article announces the filing of Form 144 for Waystar Holding Corp. on October 11. It's a concise financial notice published by Investing.com, providing basic information about a securities filing for the company.

    Investing.com UK•10/11/26•Neutral

    Form 144 Waystar Holding Corp. For: 11 October By Investing.com

    This article announces the filing of Form 144 by Waystar Holding Corp. on October 11. It's a concise financial notice from Investing.com...

    Investing.com Australia•10/11/26•Neutral

    WAY Valuation and Fair Value

    P/E
    18.6x
    Forward P/E
    12.8x
    EV/EBITDA
    15.8x
    P/FCF
    22.0x
    P/B
    1.4x
    See GNG's fair value

    WAY Profitability: Margins, ROIC and FCF

    Gross margin
    63.1%
    Operating margin
    24.4%
    Net margin
    11.2%
    ROIC
    3.5%
    ROE
    3.8%
    FCF margin
    20.4%
    FCF yield
    4.5%

    WAY Competitors

    CompanyTicker
    Mirum Pharmaceuticals IncMIRM
    Erasca IncERAS
    Merit Medical Systems IncMMSI
    Oruka Therapeutics, Inc.ORKA
    Teleflex IncorporatedTFX
    Sotera Health CoSHC
    Stevanato Group SpASTVN
    PTC Therapeutics IncPTCT

    Sector: Healthcare

    WAY Analyst Ratings

    Consensus
    Buy
    Analysts
    23
    Strong Buy
    4
    Buy
    17
    Hold
    2
    Sell
    0
    Strong Sell
    0

    WAY Bull Case vs Bear Case

    Bull case

    • WAY converts 20.4% of revenue into free cash flow.
    • WAY beat EPS estimates in 75.0% of its last 8 reported quarters.
    • WAY grew quarterly revenue 18.1% year over year.

    WAY Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    19.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.41
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    7 up, 4 down

    Frequently Asked Questions About WAY

    Does WAY pay dividends?

    Waystar Holding Corp. Common Stock (WAY) does not currently pay a regular dividend.

    What is WAY's P/E ratio?

    Waystar Holding Corp. Common Stock has a price-to-earnings (P/E) ratio of 18.58.

    What is WAY's market cap?

    Waystar Holding Corp. Common Stock (WAY) has a market capitalization of $5.15B with a current stock price of $28.24.

    Related stocks

    Sector: Healthcare

    All stocks starting with W

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In